Clinical Trial Update: Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating estriol treatment for cognitive effects in multiple sclerosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Estriol (estriol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Relapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis | Phase 2 | Status: UNKNOWN